def14a
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by
the Registrant þ
Filed by a
Party other than the Registrant
o
Check the appropriate box:
|
|
|
o
|
|
Preliminary Proxy Statement |
o
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
þ
|
|
Definitive Proxy Statement |
o
|
|
Definitive Additional Materials |
o
|
|
Soliciting Material Pursuant to §240.14a-12 |
Synergetics USA, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
þ |
|
No fee required. |
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
(1) |
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
|
|
|
|
|
|
|
|
|
|
|
(4) |
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
|
|
|
|
(5) |
Total fee paid: |
|
|
|
|
|
|
|
|
|
o |
|
Fee paid previously with preliminary materials. |
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
|
|
(1) |
Amount Previously Paid: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
Filing Party: |
|
|
|
|
|
|
|
|
|
|
|
(4) |
Date Filed: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
SYNERGETICS USA, INC.
3845 Corporate Centre Drive
OFallon, Missouri 63368
October 30,
2006
Dear Stockholder:
You are cordially invited to attend our Companys 2006
Annual Meeting of Stockholders, which will be held on
November 30, 2006, at 5:00 p.m. Central Time at The
Doubletree Hotel and Conference Center located at 16625 Swingley
Ridge Road, Chesterfield, Missouri, 63017. The formal Notice of
Annual Meeting of Stockholders and Proxy Statement accompanying
this letter describe the business to be acted upon at the
meeting.
Your vote is important to us and your shares should be
represented at the meeting whether or not you are personally
able to attend. Accordingly, I encourage you to mark, sign, date
and return the accompanying proxy promptly.
On behalf of the Board of Directors, thank you for your
continued support of Synergetics USA, Inc.
Sincerely,
GREGG D. SCHELLER
Chairman, President and Chief Executive Officer
TABLE OF CONTENTS
SYNERGETICS
USA, INC.
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To Be Held on November 30,
2006
NOTICE IS HEREBY GIVEN that the 2006 Annual Meeting of
Stockholders of Synergetics USA, Inc., a Delaware corporation
(the Company), will be held on November 30,
2006, at 5:00 p.m. Central Time at The Doubletree Hotel and
Conference Center located at 16625 Swingley Ridge Road,
Chesterfield, Missouri, 63017, to act upon the following
matters, which are described more fully in the accompanying
Proxy Statement:
1. The election of two (2) directors for terms of
office expiring at the 2006 Annual Meeting of
Stockholders; and
2. Such other business as may properly come before the
meeting
and/or any
adjournment or postponement thereof.
All holders of common stock of record at the close of business
on October 13, 2006 are entitled to notice of, and to vote
at, the Annual Meeting or any adjournment or postponement
thereof.
The Board of Directors of the Company has authorized the
solicitation of proxies. Unless otherwise directed, the proxies
will be voted FOR the election of the nominees listed in the
attached Proxy Statement to be members of the Board of Directors
of the Company and on other business that may properly come
before the Annual Meeting, as the named proxies in their best
judgment shall decide.
Any stockholder submitting a proxy may revoke such proxy at any
time prior to its exercise by notifying the Secretary of the
Company in writing at 3845 Corporate Centre Drive,
OFallon, Missouri, 63368, prior to the Annual Meeting,
and, if you attend the Annual Meeting, you may revoke your proxy
if previously submitted and vote in person by notifying the
Secretary of the Company at the Annual Meeting.
This Notice of Annual Meeting and Proxy Statement and form of
proxy are being distributed on or about October 30, 2006.
By Order of the Board of Directors,
PAMELA G. BOONE
Secretary
OFallon, Missouri
October 30, 2006
Your vote is very important.
Whether or not you plan to attend the Annual Meeting, we
encourage you to read this proxy statement and submit your proxy
as soon as possible. You may submit your proxy for the Annual
Meeting by completing, signing, dating and returning your proxy
in the pre-addressed envelope provided.
SYNERGETICS
USA, INC.
PROXY
STATEMENT
FOR THE
2006 ANNUAL MEETING OF STOCKHOLDERS
General
Information
This Proxy Statement is being furnished in connection with the
solicitation of proxies by the Board of Directors of Synergetics
USA, Inc., a Delaware corporation (the Company),
3845 Corporate Centre Drive, OFallon, Missouri, 63368, for
use at the 2006 Annual Meeting of Stockholders to be held on
November 30, 2006 at 5:00 p.m. Central Time at The
Doubletree Hotel and Conference Center located at 16625 Swingley
Ridge Road, Chesterfield, Missouri, 63017. The Board of
Directors of the Company urges you to promptly execute and
return your proxy in the enclosed envelope, even if you plan on
attending the Annual Meeting. This is designed to authenticate
stockholders identities, to allow stockholders to give
their voting instructions and to confirm that stockholders
instructions have been recorded properly.
Any stockholder submitting a proxy may revoke such proxy at any
time prior to its exercise by notifying the Secretary of the
Company, in writing, prior to the Annual Meeting. Any
stockholder attending the Annual Meeting may revoke his or her
proxy and vote personally by notifying the Secretary of the
Company at the Annual Meeting. Only stockholders of record at
the close of business on October 13, 2006, will be entitled
to notice of, and to vote at, the Annual Meeting or any
adjournment or postponement thereof. At the close of business on
October 13, 2006, the Company had 24,206,970 outstanding
shares of common stock, $.001 par value per share (the
Common Stock). Each share of Common Stock entitles
the holder thereof to one vote.
If the accompanying proxy card is signed and returned, the
shares represented thereby will be voted in accordance with the
directions on the proxy card. Unless a stockholder specifies
otherwise therein, the proxy will be voted in accordance with
the recommendations of the Board of Directors on all proposals.
The presence in person or by proxy of a majority of the voting
power represented by outstanding shares of Common Stock will
constitute a quorum for the transaction of business at the
Annual Meeting.
Directors will be elected by a plurality of the voting power
represented and entitled to vote at the meeting. The passage of
any other proposal will be determined by the affirmative vote of
the majority of the voting power represented and entitled to
vote at the meeting. In the election of directors, abstentions
and broker non-votes will not affect the outcome except in
determining the presence of a quorum; they will not be counted
toward the number of votes required for any nominees
election. An instruction to abstain from voting on
any other proposal will have the same effect as a vote against
the proposal. Broker non-votes will not be considered as present
and entitled to vote on the proposals; therefore, broker
non-votes will have no effect on the number of affirmative votes
required to adopt such proposal.
This Proxy Statement and the enclosed proxy card are being
mailed to the stockholders of the Company on or about
October 30, 2006.
PROPOSAL 1
ELECTION OF DIRECTORS
The Board of Directors of the Company currently consists of
seven (7) directors. The directors are elected to serve
three-year staggered terms. The terms of Robert H. Dick and
Juanita H. Hinshaw expire at the 2006 Annual Meeting.
Mr. Dick and Ms. Hinshaw are both being nominated for
re-election. The Board of Directors of the Company recommends a
vote FOR the two (2) nominees. If re-elected, each
nominee will serve until the annual election of directors in the
year 2009 or until his or her successor is duly elected and
qualified, or his or her earlier death, resignation or removal.
If any of the nominees are unavailable for election, an event
which the Board of Directors of the Company does not presently
anticipate, the persons named in the enclosed proxy intend to
vote the proxies solicited hereby FOR the election of such other
nominee or nominees as may be nominated by the Board of
Directors.
Based on the recommendation of the Nominating and Corporate
Governance Committee, all of the nominees have been approved
unanimously by the Board of Directors of the Company for
re-election. The Board of Directors of the Company has also
determined that each of the nominees satisfies the definition of
an independent director set forth in the marketplace
rules of The Nasdaq Stock Market, Inc. (Nasdaq). Set
forth below is information concerning the two (2) nominees
for director and the directors whose terms are continuing.
Nominees
for Directors to be Re-Elected at the 2006 Annual Meeting for
Terms Expiring in 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration
|
Name
|
|
Age
|
|
Principal Occupation and Other Information
|
|
of Term
|
|
Robert H. Dick
|
|
|
62
|
|
|
Mr. Dick has been a director of
the Company since 2005, when Synergetics, Inc. merged with
Valley Forge Scientific Corp. (Valley Forge)
(now known as Synergetics USA, Inc., or the
Company). Prior to the merger, Mr. Dick
had been a director of Valley Forge since 1997. Mr. Dick
has served as President of R.H. Dick & Company since
January 1998, which is an investment banking and management
consulting firm based in Camp Verde, Texas. From 1996 to 1998,
Mr. Dick was a partner with Boles, Knop & Company,
Inc., an investment banking firm in Middleburg, Virginia. Before
that Mr. Dick served as interim President, Chief Executive
Officer and Chief Financial Officer of Biomagnetic Therapy
Systems, Inc. and PharmX, Inc. From 1982 until 1994,
Mr. Dick served in various executive roles with
Codman & Shurtleff, Inc., a subsidiary of
Johnson & Johnson and a manufacturer of surgical
instruments, implants, equipment and other surgical products.
From 1978 to 1982, Mr. Dick was President and Chief
Executive Officer of Applied Fiberoptics, Inc., a company
designing, manufacturing and marketing fiberoptic products for
medical and defense applications, and surgical microscopes for
microsurgery. Mr. Dick also serves on the board of
Span-America Medical Systems, Inc., which designs and
manufactures wound management products and which has securities
registered pursuant to Section 12 of the Securities
Exchange Act of 1934 (the Exchange Act).
|
|
|
2009
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration
|
Name
|
|
Age
|
|
Principal Occupation and Other Information
|
|
of Term
|
|
Juanita H. Hinshaw
|
|
|
61
|
|
|
Juanita H. Hinshaw was elected as
a director of the Company in 2005 upon the merger of
Synergetics, Inc. with Valley Forge. Ms. Hinshaw has been
President and Chief Executive Officer of H&H Advisors (a
financial advisory company) since 2005. In addition,
Ms. Hinshaw served as Senior Vice President and Chief
Financial Officer of Graybar Electric Company from May 2000 to
May 2005. Graybar Electric Company specializes in supply chain
management services and distributes high-quality components,
equipment and materials for the electrical and
telecommunications industries. Ms. Hinshaw has served as a
director on the board of The Williams Companies, Inc. since
2004, IPSCO, Inc. since 2002 and Insituform Technologies, Inc.
since 1999 (IPSCO, Inc. and Insituform Technologies, Inc. have
securities registered pursuant to Section 12 of the
Exchange Act.
|
|
|
2009
|
|
Directors
Whose Terms Continue through the 2006 Annual Meeting
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration
|
Name
|
|
Age
|
|
Principal Occupation and Other Information
|
|
of Term
|
|
Gregg D. Scheller
|
|
|
50
|
|
|
Gregg D. Scheller is the
Companys President and Chief Executive Officer and has
served as the Companys Chairman of the Board since 2005.
Immediately prior to the consummation of the merger with Valley
Forge, Mr. Scheller served as President and Chief Executive
Officer of Synergetics, Inc., a Missouri corporation and now a
wholly-owned subsidiary of the Company, which he founded in
1991. Mr. Scheller had served in these positions since its
inception. Mr. Scheller has been issued 26 United States
patents (including four design patents). He devotes
substantially all of his business time to the Company.
|
|
|
2008
|
|
Kurt W. Gampp, Jr.
|
|
|
46
|
|
|
Kurt W. Gampp, Jr. is the
Companys Executive Vice President and Chief Operating
Officer and has served in these positions and as a director
since 2005. Immediately prior to the merger with Valley Forge,
Mr. Gampp served as the Executive Vice President and Chief
Operating Officer of Synergetics, Inc. and had served in this
position since Synergetics, Inc. was founded in 1991.
Mr. Gampp coordinates and supervises the manufacturing of
the Companys products and is in charge of the daily
production operations of the Company. He devotes substantially
all of his business time to the Company.
|
|
|
2008
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration
|
Name
|
|
Age
|
|
Principal Occupation and Other Information
|
|
of Term
|
|
Jerry L. Malis
|
|
|
74
|
|
|
Jerry L. Malis is the
Companys Executive Vice President and Chief Scientific
Officer and has served in these positions and as director since
2005. Immediately prior to the consummation of the merger with
Valley Forge, Mr. Malis served as Valley Forges Chief
Executive Officer, President and Chairman of the board of Valley
Forge for more than the past five years. He has published over
fifty articles in the biological science, electronics and
engineering fields, and has been issued 12 United States
patents. Mr. Malis coordinates and supervises the
scientific developments of the Company. He devotes substantially
all of his business time to the Company.
|
|
|
2008
|
|
Lawrence C. Cardinale
|
|
|
68
|
|
|
Lawrence C. Cardinale has served
as a director of the Company since Synergetics, Inc.s
merger with Valley Forge in 2005. Mr. Cardinale received
his B.S.B.A. in Business from Washington University in
St. Louis, Missouri and has recently retired after working
in the medical industry since 1966. During his over
35 years working in the field of medical manufacturing, he
has held various management positions, including Plant Manager,
Director of Manufacturing, Director of Corporate Engineering,
Director of Operations Planning, Vice President of
Manufacturing-International and Vice President-Global
Manufacturing and Engineering of a multi-national medical
manufacturing company. Mr. Cardinale also owned and
operated a scientific laboratory instrument business
concentrating in the life sciences area, which manufactured and
marketed tissue sectioning, microforge and micromanipulation
instruments and pipeting devices. Mr. Cardinale currently
serves as a board member of Coretech-Holdings LLC, a
St. Louis-based life sciences and medical device
manufacturing company and McCormick Scientific, LLC.
|
|
|
2007
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration
|
Name
|
|
Age
|
|
Principal Occupation and Other Information
|
|
of Term
|
|
Guy R. Guarch
|
|
|
65
|
|
|
Guy R. Guarch retired in 2001 from
C.R. Bard, Inc. where he spent 32 years in various sales,
marketing and management roles. Bard is a leading developer,
manufacturer and marketer of health care products used for
vascular, urological and oncological diagnosis and intervention.
From 1993 to 2001, Mr. Guarch served as Regional Vice
President Corporate Account Manager for Bards
Southeast Region. He worked as President of Bard Venture
Division in Boston, Massachusetts from 1991 to 1993. From 1988
to 1991, Mr. Guarch worked in London, England, as Vice
President of Sales for the Bard Europe Division and Managing
Director of Bard LTD, UK. Before 1988, Mr. Guarch worked in
several sales and marketing roles for Bards USCI
International Division in Boston, Massachusetts, which focused
on the design, manufacture and sale of cardiac catheters,
urological catheters and artificial arteries. Mr. Guarch
currently serves as a board member of Span-America Medical
Systems, Inc., which designs and manufactures wound management
products and which has securities registered pursuant to
Section 12 of the Exchange Act.
|
|
|
2007
|
|
BOARD AND
BOARD COMMITTEE MEETINGS,
COMMITTEE FUNCTIONS AND COMPOSITION
Directors who are neither employees of the Company nor an
immediate family member of an officer of the Company are paid
$750 for each meeting of the Board of Directors and each meeting
of a committee of the Board of Directors that they attend. The
Chairperson of the Audit Committee receives $2,250 for each
meeting of the Audit Committee. In addition, all directors are
entitled to reimbursement for travel and lodging expenses
incurred in connection with their attendance at meetings. The
full Board met four times during the fiscal year ended
July 31, 2006.
The Companys 2005 Non-Employee Directors Stock
Option Plan, adopted by the Companys Board of Directors in
May 2005 and approved by the stockholders in September 2005,
provides that each director of the Company who is neither an
employee nor an immediate family member of an officer of the
Company will be granted an option to purchase 10,000 shares
of the Companys common stock each year he or she is
elected, appointed or re-elected as a Board member. The exercise
price of options granted under this plan is equal to the fair
market value of the common stock on the date of the grant. Each
of Messrs. Dick and Guarch received a grant of the option
to purchase 10,000 shares of the Companys common
stock as of September 20, 2005, and each of
Mr. Cardinale and Ms. Hinshaw received a grant of the
option to purchase 10,000 shares of the Companys
common stock as of September 22, 2005. All options granted
under this plan vest upon issuance. Ms. Hinshaw and
Mr. Dick will receive an additional grant of
10,000 shares upon re-election.
Each of our directors attended at least 75% of all the meetings
of the Board and those committees on which he or she served
during fiscal year 2006. The Board of Directors encourages all
members to attend stockholder meetings, but has not adopted a
formal policy regarding attendance. All of the directors of
Valley Forge attended Valley Forges 2005 Annual Meeting of
Stockholders (held immediately prior to the merger), and all of
the directors of Synergetics, Inc. attended Synergetics,
Inc.s 2005 Meeting of Stockholders (held immediately prior
to the merger).
5
The Board of Directors maintains three standing committees,
including an Audit Committee, a Compensation Committee and a
Nominating and Corporate Governance Committee. Each of these
committees operates pursuant to a written charter setting forth
the functions and responsibilities of the committee, which may
be reviewed on our website at www.synergeticsusa.com and
are also available to stockholders in print upon request. In
addition, the Audit Committee Charter is included with this
proxy statement as Appendix A, and the Nominating and
Corporate Governance Committee Charter is included as
Appendix B. We intend to post any future amendments and
revisions to the charters on our website.
The Audit Committee is comprised entirely of independent
directors, as defined by The Nasdaq Stock Market listing
standards and rules of the Securities and Exchange Commission
(SEC). The Audit Committee is responsible for the
appointment, evaluation, compensation and oversight of the work
of the independent registered public accountants and, where
appropriate, the dismissal of the independent registered public
accountants. Furthermore, the Audit Committee is responsible for
meeting with the independent registered public accountants and
other corporate officers to review matters relating to financial
reporting and accounting procedures and policies. Among other
responsibilities, the Audit Committee also reviews financial
information provided to stockholders and others, assesses the
adequacy of financial, accounting, operating and disclosure
controls, evaluates the scope of the audits of the independent
registered public accounting firm and internal auditors, and
reports on the results of such audits to the Board of Directors.
In addition, the Audit Committee assists the Board of Directors
in its oversight of the performance of the Companys
independent registered public accountants. The current members
of the Audit Committee are Ms. Hinshaw (Chairperson),
Mr. Dick, and Mr. Cardinale. The Board of Directors
has determined that Ms. Hinshaw qualifies as an audit
committee financial expert as defined in Item 401(h) of
Regulation S-K
because she has served in oversight roles in finance and
accounting. The Audit Committee held six meetings during the
last fiscal year.
The Compensation Committee in composed entirely of independent
directors, as defined by The Nasdaq Stock Market listing
standards and SEC rules, and is responsible for administering
the Companys compensation programs and recommending to the
Board of Directors other compensation and benefits of the Chief
Executive Officer and other executive officers. The current
members of the Compensation Committee are Mr. Dick
(Chairperson), Mr. Cardinale and Mr. Guarch. The
Compensation Committee held three meetings during the last
fiscal year.
The members of the Companys Nominating and Corporate
Governance Committee are Mr. Cardinale (Chairperson),
Mr. Dick and Mr. Guarch, all of whom meet the
independence requirements of The Nasdaq Stock Market listing
standards and SEC rules. The Nominating and Corporate Governance
Committee is responsible for identifying individuals qualified
to become members of the Board of Directors, recommending to the
Board of Directors the director nominees to be proposed for
election by the stockholders and recommending to the Board of
Directors corporate governance guidelines and procedures
applicable to the Company. The Nominating and Corporate
Governance Committee held one meeting during 2005.
The Nominating and Corporate Governance Committee will consider
nominees recommended by stockholders of the Company. Each
stockholder must comply with applicable requirements of the
Companys Bylaws and the Exchange Act with respect to the
nomination of, or proposal of, nominees for election as
directors of the Company. Stockholders should submit any such
nominations, together with appropriate biographical information
and a description of the nominees qualifications to serve
as director, to the Chairperson of the Nominating and Corporate
Governance Committee, c/o Pamela G. Boone, Secretary,
Synergetics USA, Inc., 3845 Corporate Centre Drive,
OFallon, Missouri, 63368. The Nominating and Corporate
Governance Committee has not established specific, minimum
qualifications for director nominees that it recommends to the
Board of Directors, but instead considers all factors it deems
relevant, including sound judgment, business specialization,
technical skills, diversity and the extent to which the
candidate would fill a present need. Nominees to be evaluated by
the Nominating and Corporate Governance Committee for future
vacancies on the Board of Directors will be selected by the
Committee from candidates recommended by multiple sources,
including members of the Board of Directors, senior management,
independent search firms, stockholders and other sources, all of
whom will be evaluated based on the same criteria.
6
CORPORATE
GOVERNANCE AND WEBSITE INFORMATION
The Company has established a Code of Business Conduct and
Ethics, which is applicable to all of its employees, officers
and directors. The Code is available on the Companys
website at www.synergeticsusa.com and also available to
stockholders in print upon request. We intend to post any future
amendments and revisions to the Code of Business Conduct and
Ethics on our website.
COMMUNICATIONS
WITH THE BOARD OF DIRECTORS
Stockholders may communicate directly with the Board of
Directors, as a group, or any individual director by submitting
written correspondence addressed to them at Synergetics USA,
Inc., 3845 Corporate Centre Drive, OFallon, Missouri,
63368.
REPORT OF
THE AUDIT COMMITTEE
The Audit Committee (the Committee) oversees the
Companys financial reporting process on behalf of the
Board of Directors. Management has the primary responsibility
for the financial statements and the reporting process,
including internal control systems. The Companys
independent registered public accounting firm is responsible for
expressing an opinion on the conformity of the Companys
audited financial statements with U.S. generally accepted
accounting principles.
In fulfilling its oversight responsibilities, the Committee
reviewed with management the audited financial statements in the
Annual Report on
Form 10-K
for the year ended July 31, 2006, including a discussion of
the accounting principles, the reasonableness of significant
judgments and the clarity of disclosures in the financial
statements.
In addition, the Committee discussed with the independent
registered public accountants their judgments as to the
Companys accounting principles and such other matters as
are required to be discussed with the Committee under standards
of the Public Company Accounting Oversight Board (United States)
and SAS 61 (Codification of Statements on Auditing Standards).
The Committee met with the independent registered public
accountants, with and without management present, to discuss the
results of their examinations, their evaluations of the
Companys internal control over financial reporting, and
the overall quality of the Companys financial reporting.
The Committee has received from the independent registered
public accounting firm a formal written statement describing all
relationships between the firm and the Company that might bear
on the independence of the independent registered public
accounting firm consistent with Independence Standards Board
Standard No. 1 (Independence Discussions with Audit
Committees), discussed with the independent registered public
accounting firm any relationships that may impact their
objectivity and independence and satisfied itself as to their
independence.
In reliance on the reviews and discussions referred to above,
the Committee recommended to the Board of Directors (and the
Board has approved) that the audited financial statements be
included in the Annual Report on
Form 10-K
for the year ended July 31, 2006, filed with the SEC.
Submitted by the Audit Committee of the Board of Directors.
Juanita H. Hinshaw (Chairperson)
Lawrence C. Cardinale
Robert H. Dick
7
PRINCIPAL
STOCKHOLDERS
Security
Ownership of Certain Beneficial Owners
The following table sets forth as of October 13, 2006
certain information with respect to the beneficial ownership of
the Companys common stock by (i) each of the named
executive officers and directors, (ii) all executive
officers and directors as a group, and (iii) each person
known by the Company to beneficially own more than 5% of the
Companys common stock based on certain filings made under
Section 13 of the Exchange Act. All such information
provided by the stockholders who are not executive officers or
directors reflects their beneficial ownership as of the dates
specified in the footnotes to the table.
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Percent of
|
|
|
|
Synergetics USA
|
|
|
Shares
|
|
|
|
Shares Beneficially
|
|
|
Beneficially
|
|
Name and Address of Beneficial Owner
|
|
Owned
|
|
|
Owned
|
|
|
(i) Named Executive
Officers and
Directors(1)
|
|
|
|
|
|
|
|
|
Gregg D. Scheller (2),(3)
|
|
|
807,840
|
|
|
|
3.3
|
%
|
Lawrence C. Cardinale (2),(4)
|
|
|
22,612
|
|
|
|
*
|
|
Robert H. Dick (2),(5)
|
|
|
74,000
|
|
|
|
*
|
|
Kurt W.
Gampp, Jr. (2),(6)
|
|
|
958,392
|
|
|
|
4.0
|
%
|
Guy R. Guarch (2),(7)
|
|
|
12,000
|
|
|
|
*
|
|
Juanita H. Hinshaw (2),(8)
|
|
|
326,710
|
|
|
|
1.4
|
%
|
Jerry L. Malis (2),(9)
|
|
|
1,182,276
|
|
|
|
4.9
|
%
|
Pamela G. Boone (2),(10)
|
|
|
16,387
|
|
|
|
*
|
|
(ii) All Executive
Officers and Directors as a Group (8 persons)
|
|
|
3,400,217
|
|
|
|
14.0
|
%
|
(iii) Certain Beneficial
Owners
|
|
|
|
|
|
|
|
|
None.
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Less than 1%. |
|
(1) |
|
Except as indicated in the footnotes to this table, the persons
named in the table have sole voting and investment power with
respect to all shares of common stock shown as beneficially
owned the them. |
|
(2) |
|
The mailing address of Messrs. Scheller, Cardinale, Dick,
Gampp, Guarch and Malis and Mses. Hinshaw and Boone is 3845
Corporate Centre Drive, OFallon, Missouri, 63368. |
|
(3) |
|
Includes shares held in the Gregg D. Scheller Trust.
Mr. Scheller, in his capacity as trustee, possesses sole
voting and investment power with respect to these shares. This
does not include 817,020 shares held by the Donna Scheller
Trust, of which Mr. Schellers wife is trustee.
Mr. Scheller disclaims beneficial ownership as to these
shares. |
|
(4) |
|
Includes 10,000 shares issuable to Mr. Cardinale
subject to options exercisable currently or within 60 days. |
|
(5) |
|
Includes 74,000 shares issuable to Mr. Dick subject to
options exercisable currently or within 60 days. |
|
(6) |
|
Includes shares held in the Kurt W. Gampp, Jr. Trust. This
does not include 8,225 shares held by the Julie Gampp
Trust, of which Mr. Gampps wife is trustee, nor
62 shares held by his daughter, Lindsey Gampp.
Mr. Gampp disclaims beneficial ownership as to these shares. |
|
(7) |
|
Includes 10,000 shares issuable to Mr. Guarch subject
to options exercisable currently or within 60 days. |
|
(8) |
|
Includes shares held in the Hinshaw-Harrison Joint Revocable
Living Trust. Ms. Hinshaw, in her capacity as trustee,
possesses joint voting and investment power with respect to
these shares. Also includes 10,000 shares issuable to
Ms. Hinshaw subject to options exercisable currently or
within 60 days. |
|
(9) |
|
Includes 50,000 shares issuable to Mr. Malis subject
to options exercisable currently or within 60 days. Also
includes 200,000 shares held in the Malis Family L.P., a
limited partnership in which Jerry L. Malis is the general
partner and possesses voting and investment power. |
8
|
|
|
(10) |
|
Includes 6,387 shares issued to Ms. Boone subject to
restrictions including a cliff vesting period of five years from
the date of the grant in March, 2006. |
COMPLIANCE
WITH SECTION 16(a) OF THE SECURITIES AND EXCHANGE
ACT
Section 16(a) of the Exchange Act requires the
Companys directors and executive officers, and persons who
own more than 10% of a registered class of the Companys
equity securities, to file reports of ownership of, and
transactions in, the Companys securities with the SEC and
The Nasdaq Stock Market. Such directors, executive officers and
10% stockholders are also required to furnish the Company with
copies of all Section 16(a) forms they file.
Based solely upon a review of reports furnished to the Company,
and on written representations from certain reporting persons,
the Company believes that, with respect to the fiscal year ended
July 31, 2006, each director, executive officer and 10%
stockholder of the Companys securities made timely filings
of all reports required by Section 16 of the Exchange Act,
except as follows: Messrs. Cardinale, Dick and Guarch and
Ms. Hinshaw each filed a late Form 4 reporting their
grants of stock options pursuant to the 2005 Non-Employee
Directors Stock Option Plan (Mr. Cardinales
Form 4 was filed on November 14, 2005 for awards
granted on September 22, 2005; Mr. Dicks
Form 4 was filed on May 3, 2006 for awards granted on
September 20, 2005; Mr. Guarchs Form 4 was
filed on November 4, 2005 for awards granted on
September 20, 2005; Ms. Hinshaws Form 4 was
filed on November 4, 2005 for awards granted on
September 22, 2005). Mr. Cardinale filed a late
Form 4 on October 20, 2006 for a distribution of
shares on November 3, 2005. Ms. Boone filed a late
Form 4 on May 3, 2006 reporting her grant of
restricted stock options on March 7, 2006.
EXECUTIVE
OFFICERS
The following table sets forth certain information, as of the
date of this proxy statement, with respect to the executive
officers of the Company.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position(s) with the Company
|
|
Gregg D. Scheller
|
|
|
50
|
|
|
President, Chief Executive
Officer & Chairman of the Board of Directors
|
Kurt W. Gampp, Jr.
|
|
|
46
|
|
|
Executive Vice President, Chief
Operating Officer & Director
|
Jerry L. Malis
|
|
|
74
|
|
|
Executive Vice President, Chief
Scientific Officer & Director
|
Pamela G. Boone
|
|
|
43
|
|
|
Executive Vice President, Chief
Financial Officer, Treasurer & Secretary
|
The biographical information for Messrs. Scheller, Gampp
and Malis can be found under Proposal 1
Election of Directors above.
Ms. Boone joined the Company as its Chief Financial Officer
in May 2005. Prior to this, Ms. Boone served as Vice
President and Chief Financial Officer of Maverick Tube
Corporation from 2001 until January 2005 and as Vice President,
Treasurer and acting Chief Financial Officer until May 2005.
Maverick Tube Corporation, a Missouri-based company, was a
leading North American producer of welded tubular steel products
used in energy and industrial applications. From 1997 to 2001,
Ms. Boone served as Mavericks Corporate Controller.
9
EXECUTIVE
COMPENSATION
The following table sets forth the cash and non-cash
compensation awarded to or earned by each of the executive
officers of the Company named below (the Named Executive
Officers) for each of the last three fiscal years.
Summary
Compensation Table
The following table sets forth the aggregate compensation paid
by Synergetics or Valley Forge, as the case may be, with respect
to the three fiscal years ended July 31, 2006, 2005 and
2004 to Mr. Scheller, Mr. Malis, Mr. Gampp and
Ms. Boone, its Chief Executive Officer, Chief Scientific
Officer, Chief Operating Officer and Chief Financial Officer,
respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
Restricted
|
|
Underlying
|
|
|
|
|
Fiscal
|
|
|
|
|
|
Stock
|
|
Options
|
|
All Other
|
Name and Principal Position
|
|
Year
|
|
Salary
|
|
Bonus
|
|
Awards
|
|
Granted
|
|
Compensation(1)
|
|
Gregg D. Scheller
|
|
|
2006
|
|
|
$
|
377,000
|
|
|
$
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
President and
|
|
|
2005
|
|
|
|
409,740
|
(2)
|
|
|
39,433
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chief Executive Officer
|
|
|
2004
|
|
|
|
285,972
|
|
|
|
19,000
|
|
|
|
|
|
|
|
|
|
|
$
|
2,000
|
|
Jerry L. Malis(3)
|
|
|
2006
|
|
|
$
|
230,000
|
|
|
$
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Vice President and
|
|
|
2005
|
|
|
|
226,306
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chief Scientific Officer
|
|
|
2004
|
|
|
|
220,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kurt W. Gampp, Jr.
|
|
|
2006
|
|
|
$
|
346,000
|
|
|
$
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Vice President and
|
|
|
2005
|
|
|
|
385,775
|
(2)
|
|
|
52,231
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chief Operating Officer
|
|
|
2004
|
|
|
|
238,617
|
|
|
|
19,000
|
|
|
|
|
|
|
|
|
|
|
$
|
2,000
|
|
Pamela G. Boone(4)
|
|
|
2006
|
|
|
$
|
179,423
|
|
|
$
|
5,000
|
|
|
$
|
35,000
|
(5)
|
|
|
|
|
|
|
|
|
Executive Vice President,
|
|
|
2005
|
|
|
$
|
31,635
|
|
|
|
|
|
|
|
|
|
|
|
41,310
|
(6)
|
|
|
|
|
Chief Financial Officer,
|
|
|
2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasurer and Secretary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
All Other Compensation for Messrs. Scheller and
Gampp represents compensation they received for serving as
members of the Synergetics, Inc. board of directors. |
|
(2) |
|
The salaries of Messrs. Scheller and Gampp for fiscal year
2005 contained an incentive compensation arrangement that was
based upon Synergetics sales. In fiscal year 2006, their
salaries were based upon their employment contracts that are
described in the section Employment Agreements and
Severance Agreements. |
|
(3) |
|
The historical compensation disclosed for Mr. Malis is that
received by Mr. Malis as Chief Executive Officer of Valley
Forge. |
|
(4) |
|
Ms. Boones employment as Synergetics Chief
Financial Officer did not begin until May 19, 2005. |
|
(5) |
|
The restricted stock holdings of Ms. Boone were
6,387 shares representing $28,869 of value at the end of
fiscal year 2006. The restricted stock will vest 100% on
March 7, 2011. Dividends will be paid on this restricted
stock if the Company grants dividends to its common stockholders. |
|
(6) |
|
The number of shares underlying options granted to
Ms. Boone give effect to the conversion ratio of
4.59 shares of Valley Forge common stock for each share of
Synergetics, Inc. common stock, pursuant to the terms of the
merger. |
Option
Grants in Last Fiscal Year
There were no options granted to any named executive officer
during the fiscal year ended July 31, 2006.
10
Aggregate
Fiscal Year End Option Values
The following table sets forth the value on July 31, 2006
for unexercised options for Synergetics USAs Chief
Scientific Officer and Chief Financial Officer.
Mr. Scheller and Mr. Gampp did not have options to
purchase Synergetics USA common stock as of July 31, 2006.
No named executive officer exercised any options during the
fiscal year ended July 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of Unexercised
|
|
|
Number of Securities Underlying Unexercised
|
|
In-the-Money
Options at
|
Name
|
|
Options at Fiscal Year End
|
|
Fiscal Year End
|
|
Jerry L. Malis
|
|
|
50,000 Exercisable/0 Unexercisable(1
|
)
|
|
$
|
169,750
|
|
Pamela G. Boone
|
|
|
0 Exercisable/41,310 Unexercisable(2
|
)
|
|
$
|
121,735
|
|
|
|
|
(1) |
|
These options were granted on December 12, 2000 with an
exercise price of $1.125 per share and expire on
December 12, 2010. All of these options are exercisable at
July 31, 2006. |
|
(2) |
|
These options were granted on May 19, 2005 with an exercise
price of $1.089 per share and expire on May 19, 2015.
One-half of these shares become exercisable on May 19, 2009
and the remainder become exercisable on May 19, 2010. The
number of shares underlying options granted to Ms. Boone
and the exercise price give effect to the conversion ratio of
4.59 shares of Valley Forge common stock for each share of
Synergetics common stock, pursuant to the terms of the merger. |
EXISTING
EQUITY COMPENSATION PLAN INFORMATION
The table below shows information with respect to all of our
equity compensation plans as of July 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares of
|
|
|
|
|
|
|
|
|
|
Common Stock Available
|
|
|
|
|
|
|
|
|
|
for Future Issuance
|
|
|
|
Number of Shares of
|
|
|
|
|
|
Under Equity
|
|
|
|
Common Stock to be
|
|
|
|
|
|
Compensation Plans at
|
|
|
|
Issued Upon Exercise of
|
|
|
Weighted Average
|
|
|
July 31, 2006
|
|
|
|
Outstanding Options,
|
|
|
Exercise Price of
|
|
|
(Excluding Shares
|
|
|
|
Warrants and Rights at
|
|
|
Outstanding Options,
|
|
|
Reflected in the First
|
|
Plan Category
|
|
July 31, 2006
|
|
|
Warrants and Rights
|
|
|
Column)
|
|
|
Equity Compensation Plans
Approved By Security Holders
|
|
|
411,750
|
|
|
$
|
1.98
|
|
|
|
1,259,383
|
|
Equity Compensation Plans Not
Approved By Security Holders
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
411,750
|
|
|
$
|
1.98
|
|
|
|
1,259,383
|
|
EMPLOYMENT
AGREEMENTS AND SEVERANCE AGREEMENTS
Each of Mr. Scheller, Mr. Malis and Mr. Gampp
have entered into three-year employment agreements with the
Company. Pursuant to the agreements, Mr. Schellers
base salary is $377,000, Mr. Malis base salary is
$230,000 and Mr. Gampps salary is $346,000. In
addition, each of them shall receive such other benefits,
including healthcare, dental, life insurance, disability and
30 days of paid vacation that the Company provides to its
executive officers. Each of Messrs. Scheller, Malis and
Gampp may receive an annual bonus as determined in the sole
discretion of the Compensation Committee of the Companys
Board of Directors. In the event any of such executive officers
are terminated without cause, or if any such executive officer
resigns for good reason, such executive officer shall be
entitled to his base salary and health care benefits through the
end of the term of his employment agreement.
As used in the employment agreements with Messrs. Scheller,
Malis and Gampp, cause means (1) the executive
officers conviction of any felony, or conviction for
embezzlement or misappropriation of Company money or other
property; (2) any act of gross negligence in performing the
executive officers duties; (3) the
11
executive officers willful refusal to execute his duties
(other than for disability); or (4) the executive
officers breach of the non-competition terms contained in
his employment agreement. Termination for the events described
in clauses (2) and (3) above will not constitute
termination for cause unless the executive officer
is provided written notice reasonably detailing such occurrence
and is given five business days after receipt of such notice to
cure such event and an opportunity to be heard before the
Companys Board of Directors.
As used in the employment agreements with Messrs. Scheller,
Malis and Gampp, the term good reason means
(1) failure to pay, or a reduction, by the Company of the
executive officers base salary; (2) the failure or
refusal by the Company to provide the executive officer with the
benefits set forth in his employment agreement; (3) the
assignment to the executive officer of any duties materially
inconsistent with the duties set forth in the employment
agreement, which assignment is not cured within five business
days of written notice to the Company; (4) in the case of
Mr. Malis, a requirement imposed by the Company on
Mr. Malis that results in Mr. Malis being based at a
location that is outside a
35-mile
radius of Valley Forges former corporate offices in
suburban Philadelphia, Pennsylvania, and in the case of
Messrs. Scheller and Gampp, 35 miles from the
Companys current corporate offices in OFallon,
Missouri; (5) a change in the executive officers
title; (6) if the executive officer is no longer a member
of the Companys Board of Directors, other than by death,
disability or a removal by a shareholder vote for cause;
(7) any material breach by the Company of the employment
agreement, which breach is not cured within five business days
after receipt of written notice from the executive officer; or
(8) the termination of the executive officers
employment other than for cause, death or disability.
The employment agreements for each of Messrs. Scheller,
Malis and Gampp contain non-competition and non-solicitation
provisions, depending on the circumstances of any termination of
employment. Furthermore, each of them has agreed that any
products, inventions, discoveries and improvements made by him
during the employment term shall be the property of the Company.
REPORT OF
THE COMPENSATION COMMITTEE ON EXECUTIVE COMPENSATION
The Compensation Committee of the Board of Directors
(Compensation Committee) reviews each salary
adjustment and bonus for the Companys officers and
recommends those adjustments to the full Board. The Compensation
Committee also provides recommendations to the full Board
regarding the Companys 2001 Stock Plan, which is a part of
the Companys incentive plan. The Compensation Committee
also provides recommendations regarding Director and Advisory
Director compensation.
The Compensation Committees objectives are as follows:
1. The Compensation Committee seeks to establish executive
compensation to attract and retain the necessary management
talent to successfully lead the Company. The Compensation
Committee believes that the Company must provide a compensation
package for the Companys key executives, which is
competitive with compensation packages offered by other
comparable companies.
2. The Compensation Committee believes that the Company
should encourage decision-making that enhances shareholder
value. The Compensation Committee believes that this objective
is met by linking some portion of executive pay to corporate
performance.
The Compensation Committee believes that the compensation
structure of the Company is reasonably designed to achieve the
above stated objectives. Total compensation for the
Companys executive officers is determined by marketplace
survey data, Company performance and individual performance.
In determining its compensation recommendations to the Board of
Directors, the Compensation Committee establishes a salary range
for each executive based on information concerning executive
compensation available to the Compensation Committee, including
information relating to executive compensation at companies of
comparable size. The Compensation Committee recommends to the
Board of Directors a compensation package for each Company
executive. This compensation package consists of base wages,
bonuses and accompanying benefits. The Committee also retains
discretion to award incentive pay depending on the circumstances
and financial strength of the Company.
12
The total compensation package is intended to place the
executive within the compensation range targeted by the
Compensation Committee for the executives position.
For the year ended July 31, 2006, the Compensation
Committee considered three key elements of Company performance
in determining executive compensation, including that of its
Chief Executive Officer, Mr. Scheller: the Companys
achievement of its sales forecasts and sales planning
strategies; the successful post-merger integration of Valley
Forge and Synergetics, Inc.; and the Companys ability to
improve the effectiveness of its internal financial reporting
and controls, including the avoidance of financial reporting
issues. Although the Compensation Committee believes a
compensation policy focusing on profit margin and earnings per
share would be more appropriate under normal circumstances, the
performance considerations for the year ended July 31,
2006, were established in recognition of the unique challenges
facing the Company, its senior management and, in particular,
Mr. Scheller in a year of complex transition. While no
specific compensation awards were set for achievement of the
performance objectives, the Compensation Committee concluded
that the Companys executive compensation packages,
including that of Mr. Scheller, were consistent with
managements performance, reasonable in view of market
conditions and competitive with compensation at comparable
companies. The Compensation Committee has yet to determine
whether any discretionary bonuses will be awarded retroactively
to any of the Companys executives for the fiscal year
ended July 31, 2006.
Submitted by the Compensation Committee of the Board of
Directors.
Robert H. Dick (Chairperson)
Lawrence C. Cardinale
Guy R. Guarch
COMPENSATION
COMMITTEE INTERLOCKS
AND INSIDER PARTICIPATION
All executive officer compensation decisions are made by the
Companys Compensation Committee. The Compensation
Committee also reviews and makes recommendations to the Board of
Directors regarding the compensation of our senior management
and key employees, including salaries and bonuses. As of
July 31, 2006, the members of the Compensation Committee
for Synergetics USA, Inc. are Mr. Robert H. Dick
(chairperson), Mr. Lawrence C. Cardinale and Mr. Guy
R. Guarch.
No member of the Compensation Committee of Synergetics USA, Inc.
during fiscal 2006 was an employee or officer of Synergetics
USA, Inc. or any of its subsidiaries. During the year ended
July 31, 2006, no executive officer of the Company served
as a member of (i) the compensation committee of another
entity in which one of the executive officers of such entity
served on the Companys Compensation Committee,
(ii) the Board of Directors of another entity in which one
of the executive officers of such entity served on the
Companys Compensation Committee, or (iii) the
compensation committee of another entity in which one of the
executive officers of such entity served as a member of the
Companys Board of Directors.
Valley Forge prior to its combination with Synergetics USA, Inc.
retained R.H. Dick & Company, Inc., an investment
banker and business consulting company owned by Mr. Robert
H. Dick, one of our directors, to perform investment banking and
business consulting services. For the fiscal years ended 2004,
Valley Forge incurred consulting expenses from these services of
$15,000, excluding the reimbursement of
out-of-pocket
expenses. The Company did not engage this company during the
fiscal year ending July 31, 2006 and does not expect to
engage them during the fiscal year ending July 31, 2007.
13
STOCK
PERFORMANCE GRAPH
The graph below compares the cumulative total stockholder return
on an investment in our common stock, the NASDAQ common stock
market and an index of a peer group of medical companies (the
Peer Group) for the five-year period ended
July 31, 2006. The peer group is composed of four small
companies whose primary business is ophthalmology: Escalon
Medical Corporation, Inspire Pharmaceutical Inc., Iridex
Corporation and STAAR Surgical Company. The graph assumes the
value of an investment in the common stock and each index as
$100 at August 1, 2001 and that all dividends were
reinvested.
STOCK
PERFORMANCE GRAPH
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
Since the late 1960s, the late Dr. Leonard Malis, one
of Valley Forges former directors, on an individual basis
has been a party to consulting and other agreements with
Codman & Shurtleff, Inc., the Companys principal
customer. Since 1983, Dr. Malis has been a party to an
agreement with Codman under which Dr. Malis received
royalty payments for the use of the
Malis®
trademark on certain products sold by Codman to end users,
including products Valley Forge sold to Codman. Dr. Malis
developed passive hand instruments for Codman with no pecuniary
benefits to Valley Forge. On October 22, 2004, Valley Forge
entered into an option agreement with Dr. Malis under which
Valley Forge was granted an option to acquire the
Malis®
trademark from Dr. Malis at any time over a period of five
years. Valley Forge paid Dr. Malis $35,000 for the option
and is required to pay an annual fee before each anniversary of
the option agreement of $20,000 for each of the first two
anniversaries and increasing to $60,000 before the fourth
anniversary in order to continue the option in effect from year
to year.
On October 12, 2005, the Company exercised its option with
respect to the
Malis®
trademark. We paid the estate of Dr. Leonard I. Malis
$159,904 in cash and the remainder in a $3,997,600 promissory
note which will be paid in 25 equal quarterly installments of
$159,904. The Company has made three quarterly payments on this
note during the year ended July 31, 2006. The promissory
note is secured by a security interest in the trademark and our
DualWavetm
patents.
For the year ended July 31, 2006, Valley Forge (prior to
the merger) paid legal fees in the amount of $89,560 to a law
firm in which a
son-in-law
of Jerry L. Malis is a partner.
Commencing in fiscal 2005, and prior to the merger, Valley Forge
engaged Mr. Bruce A. Murray, a director of Valley Forge to
perform certain business consulting services and other operating
duties. For the
14
year ended July 31, 2006, he received a salary of $44,385,
excluding reimbursement of
out-of-pocket
services. As of the completion of the merger, Mr. Murray is
no longer a director of the Company and no longer performs
consulting services or other operating duties for the Company.
INFORMATION
REGARDING INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
Before Synergetics, Inc.s merger with Valley Forge,
completed on September 21, 2005, Rotenberg Meril Solomon
Bertiger & Guttilla, P.C. (RMSB&G)
was retained by Valley Forge to serve as its independent
registered public accounting firm, after the resignation of
Samuel Klein and Company on January 20, 2005. Prior to the
consummation of the merger, Synergetics, Inc. retained the
services of McGladrey & Pullen, LLP to audit its
financial statements for inclusion in Valley Forges
registration statement on
Form S-4
filed in connection with the merger.
On October 20, 2005, the Audit Committee of the Board of
Directors of the Company terminated RMSB&Gs
appointment as the Companys independent registered public
accounting firm. During RMSB&Gs engagement, RMSB&G
did not report on the financial statements for either Valley
Forge or the Company. Thus, there were no disagreements with
RMSB&G on any matter of accounting principles or practices,
financial statement disclosure or auditing scope or procedure,
which disagreements, if not resolved to the satisfaction of
RMSB&G, would have caused it to make reference to the
subject matter of the disagreement in connection with its
report. Furthermore, none of the reportable events described in
Item 304(a)(1)(v) of
Regulation S-K
occurred during RMSB&Gs engagement.
Effective October 20, 2005, the Audit Committee of the
Board of Directors of the Company appointed McGladrey &
Pullen, LLP as the Companys new independent registered
public accounting firm. Valley Forge did not consult with
McGladrey & Pullen, LLP with respect to any of the
matters or reportable events set forth in Item 304(a)(2)(i)
and (ii) of
Regulation S-K.
Since the engagement of McGladrey & Pullen, LLP, the
Company has not consulted with McGladrey & Pullen, LLP
with respect to any of the matters or reportable events set
forth in Item 304(a)(2)(i) and (ii) of
Regulation S-K.
The following table shows fees billed for professional services
rendered by McGladrey & Pullen, LLP for the years ended
2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended
|
|
|
Fiscal Year Ended
|
|
|
|
July 31, 2006
|
|
|
July 31, 2005
|
|
|
Audit Fees
|
|
$
|
506,000
|
(a)
|
|
$
|
355,000
|
(b)
|
Audit-Related Fees
|
|
|
0
|
|
|
|
0
|
|
Tax Fees(c)
|
|
|
0
|
|
|
|
0
|
|
All Other Fees
|
|
|
0
|
|
|
|
0
|
|
Total
|
|
$
|
506,000
|
|
|
$
|
355,000
|
|
|
|
|
(a) |
|
Audit Fees for the fiscal year ended July 31, 2006 include
services for the audit of the consolidated financial statements,
report on managements assessment of the Companys
internal control over financial reporting, the review of the
quarterly financial statements, filings of registration
statements with the SEC, comfort letters for underwriters,
consultation concerning financial accounting and reporting
standards and international statutory audits. The amount
included here is an estimate from the accounting firm as the
final invoice for the year has not been rendered. |
|
(b) |
|
Audit Fees for the fiscal year ended July 31, 2005 includes
fees for assistance with and review of SEC filings and related
documents, including two years of audits (audit of fiscal year
ended July 31, 2005 and re-audit of fiscal year ended
July 31, 2004) and for certain quarterly and other
review services. |
|
(c) |
|
Tax Fees are comprised of fees relating to income tax matters,
planning and advice. |
Pursuant to the Audit Committees charter, all audit and
permissible non-audit services provided by the independent
registered public accounting firm must be pre-approved. These
services may include audit services, audit-related services, tax
services and other services. Pre-approval is generally provided
for up to one year and any pre-approval is detailed as to the
particular service or category of service. The independent
15
registered public accounting firm and management are required to
periodically report to the Audit Committee regarding the extent
of services provided by the independent registered public
accounting firm in accordance with the policies set forth in the
Audit Committee charter. Consistent with the Audit
Committees policy, all audit and permissible non-audit
services provided by McGladrey & Pullen, LLP during the
fiscal years ended July 31, 2006 and 2005 were pre-approved
by the Audit Committee.
In considering the nature of the services provided by the
independent registered public accounting firm, the Audit
Committee determined that such services are compatible with the
provision of independent audit services. The Audit Committee
discussed these services with the independent registered public
accounting firm and management to determine that they are
permitted under the rules and regulations concerning
auditors independence promulgated by the SEC to implement
the Sarbanes-Oxley Act of 2002, as well as rules of the American
Institute of Certified Public Accountants.
OTHER
MATTERS
Management does not know of any other business that may be
considered at the Annual Meeting. However, if any matters other
than those referred to above should properly come before the
Annual Meeting, it is the intention of the persons named in the
accompanying form of proxy to vote the proxies held by them in
accordance with their best judgment.
The Company will bear the costs of its solicitation of proxies.
In addition to the use of the mails, proxies may be solicited by
electronic mail, personal interview, telephone, telegram and
telefax by the directors, officers and employees of the Company.
Arrangements will also be made with brokerage houses and other
custodians, nominees and fiduciaries for the forwarding of
solicitation material to the beneficial owners of stock held of
record by such persons, and the Company may reimburse such
custodians, nominees and fiduciaries for reasonable
out-of-pocket
expenses incurred by them in connection therewith.
FORM 10-K
Along with mailing the proxy materials, we have included a copy
of our Annual Report on
Form 10-K
for the year ended July 31, 2006. We will provide
stockholders with additional copies of our Annual Report on
form 10-K
for the year ended July 31, 2006, without charge, upon
written request to Pamela G. Boone, Secretary, Synergetics USA,
Inc., 3845 Corporate Centre Drive, OFallon, Missouri,
63368.
HOUSEHOLDING
OF PROXY MATERIALS
The SEC has adopted rules that permit companies and
intermediaries (e.g. brokers) to satisfy the delivery
requirements for proxy statements with respect to two or more
stockholders sharing the same address by delivering a single
proxy statement addressed to those stockholders. This process,
which is commonly referred to as householding,
potentially means extra convenience for stockholders and cost
savings for companies.
A number of brokers with accountholders who are stockholders
will be householding our proxy materials. As indicated in the
notice previously provided by these brokers to stockholders, a
single proxy statement will be delivered to multiple
stockholders sharing an address unless contrary instructions
have been received from an affected stockholder. Once you have
received notice from your broker or us that they will be
householding communications to your address, householding will
continue until you are notified otherwise.
Stockholders who currently receive multiple copies of the proxy
statement at their address and would like to request
householding of their communications should contact their broker
or, if a stockholder is a direct holder of shares of our common
stock, they should submit a written request to our transfer
agent, American Stock Transfer & Trust Company, 6201
15th Avenue, Brooklyn, New York, 11219. To delist yourself
from householding in the future you may write the Company at
3845 Corporate Centre Drive, OFallon, Missouri, 63368,
Attention: Pamela G. Boone. Upon request, we will deliver
promptly a separate copy of the proxy statement.
16
STOCKHOLDER
PROPOSALS FOR 2007 ANNUAL MEETING OF STOCKHOLDERS
Stockholder proposals submitted for inclusion in the proxy
statement and form of proxy for the 2007 Annual Meeting of
Stockholders must be received at the corporate offices of the
Company, addressed to the attention of Ms. Pamela G. Boone,
Secretary, Synergetics USA, Inc. no later than July 2,
2007. The proposals must comply with the rules of the SEC
relating to stockholder proposals. The Companys Bylaws
provide that no business may be brought before an annual meeting
unless specified in the notice of meeting, brought before the
meeting by or at the direction of the Board of Directors, or
otherwise brought by a stockholder who has delivered notice to
the Company (containing certain information specified in the
Bylaws) not less than 60 or more than 90 days before the
anniversary date of the immediately preceding annual meeting of
stockholders. A copy of the full text of these Bylaw provisions
may be obtained by writing to the Secretary at the address
indicated above.
By Order of the Board of Directors,
PAMELA G. BOONE
Secretary
October 30, 2006
17
Appendix A
SYNERGETICS
USA, INC.
AUDIT COMMITTEE CHARTER
The primary purpose of the Audit Committee (the
Committee) is to assist the Board of Directors (the
Board) in fulfilling its responsibility to oversee
management regarding: (1) the conduct of the Companys
financial reporting process, including the overview of the
integrity of the financial reports and other financial
information provided by the Company to any governmental or
regulatory body, the public or other users thereof; (2) the
performance of the Companys systems of internal
accounting, financial controls and audit function; (3) the
performance of the Companys independent auditors,
including their qualifications and independence, and the annual
independent audit of the Companys financial statements;
(4) the preparation of the audit committee report required
by the rules promulgated by the Securities and Exchange
Commission (SEC) to be included in the
Companys annual proxy statement; and (5) the
Companys legal and regulatory compliance.
The Committee shall review the adequacy of this Charter at least
annually.
The Committee shall be comprised of not less than three members
of the Board, all of whom shall be independent, and the
Committees composition will meet all of the rules and
guidelines of The Nasdaq Stock Market and any requirements of
the Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley) or
rules adopted by the SEC relating to audit committees.
The members of the Committee shall be elected by the Board at
the annual organizational meeting of the Board to serve until
their successors shall be duly elected and qualified. Unless a
chair of the Committee is elected by the full Board, the members
of the Committee may designate a chair by majority vote of the
full Committee membership. Any member of the Committee may be
removed, with or without cause, by the Board at any time.
The Committee shall meet as often as it deems necessary or
appropriate, generally at least four times annually, or more
frequently as circumstances dictate. The Committee may ask
members of management or others to attend meetings and provide
pertinent information as necessary. As part of its role to
foster open communication and to discharge its oversight role,
the Committee or its chairperson should meet periodically with
management, and the independent auditors and the Committee
should meet in separate sessions to discuss any matters the
Committee believes should be discussed privately. Meetings and
sessions of the Committee may be held telephonically.
|
|
4.
|
KEY
RESPONSIBILITIES AND AUTHORITY
|
The Committees role is one of oversight. It recognizes
that the Companys management is responsible for preparing
the Companys financial statements, and the independent
auditors are responsible for auditing those financial
statements. Additionally, the Committee recognizes that
financial management and the independent auditors, have more
time, knowledge and detailed information on the Company than do
Committee members. Consequently, in carrying out its oversight
responsibilities, the Committee is not providing any expert or
special assurance as to the Companys financial statements
or any professional certification as to the independent
auditors work.
In discharging its oversight role, the Committee may investigate
any matter brought to its attention with full access to all
books, records, facilities and personnel of the Company. The
Committee has the power to
A-1
retain outside counsel, auditors or other experts for this
purpose and will receive funding from the Company to engage such
advisors. The independent auditors are ultimately accountable to
the Committee.
The following functions and responsibilities are set forth as a
guide with the understanding that the Committee may diverge from
this guide as appropriate given the circumstances.
To fulfill its role, the Committee shall:
(a) Continuous Activities General
(i) Have the direct responsibility for the appointment,
evaluation, compensation and oversight of the work of the
independent auditors and, where appropriate, the dismissal of
the independent auditors. The independent auditors shall report
directly to the Committee, and the Committees
responsibility includes the resolution of disagreements between
management and the independent auditors regarding financial
reporting;
(ii) Report its findings regularly to the Board, including
any issues that arise with respect to the quality or integrity
of the Companys financial statements, the Companys
compliance with legal or regulatory requirements, the
performance and independence of the independent auditors;
(iii) Consider and pre-approve all auditing services
provided by the Companys independent auditors. All
non-audit services permitted pursuant to law to be provided by
the auditors must also be considered and pre-approved by the
Committee, and such approvals must be disclosed in the
Companys periodic public filings. The Committee may
delegate the authority to grant pre-approvals to one or more
members of the Committee, whose decisions must be presented to
the full Committee at its scheduled meetings;
(iv) Consider and review with the independent auditors and
management: (1) the adequacy of the Companys
disclosure controls and procedures and internal controls;
(2) all significant deficiencies in the design or operation
of the Companys internal controls which could adversely
affect the Companys ability to record, process, summarize
and report financial data; (3) any material fraud against
the Company involving any employee; (4) any fraud, whether
or not material, that involves management or other employees who
have a significant role in the Companys internal controls;
and (5) the related findings and recommendations of the
independent auditors together with managements responses;
(v) Consider and review with management, the Chief
Financial Officer and the independent auditors:
(1) significant findings during the year, including the
status of previous audit recommendations; (2) any audit
problems or difficulties encountered in the course of audit
work, including any restrictions on the scope of activities or
access to required information; (3) any changes required in
the planned scope of the audit plan; (4) the audit budget
and staffing; and (5) the coordination of audit efforts in
order to monitor completeness of coverage, reduction of
redundant efforts and the effective use of audit resources;
(vi) Inquire of management, the independent auditors and
the Chief Financial Officer about significant risks or exposures
and assess the steps management has taken to minimize such
risks. The Committee shall discuss with management, the
independent auditors and the Chief Financial Officer or
Controller and oversee the Companys underlying policies
with respect to risk assessment and risk management; and
(vii) Establish and maintain procedures for the receipt,
retention and treatment of complaints received by the Company
regarding accounting, internal accounting controls or auditing
matters and the confidential, anonymous submissions by employees
of concerns regarding questionable accounting or auditing
matters.
(b) Continuous Activities Specific Reporting
Policies and Scheduled Activities
(i) Review and discuss with management and the independent
auditors the accounting policies that may be viewed as critical
and review and discuss any significant changes in the accounting
A-2
policies of the Company and any accounting and financial
reporting proposals that may have a significant impact on the
Companys financial reports. The Committee shall inquire as
to the independent auditors views about whether
managements choices of accounting principles are
conservative, moderate or aggressive from the perspective of
income, asset and liability recognition and whether those
principles are common practices or are minority practices;
(ii) Review and discuss with management and the independent
auditors any material financial or non-financial arrangements of
the Company that do not appear on the financial statements of
the Company. The Committee shall review, discuss with management
and the independent auditors and approve any transactions or
courses of dealing with related parties (e.g., significant
shareholders of the Company, directors, corporate officers or
other members of senior management or their family members) that
are significant in size or involve terms or other aspects that
differ from those that would likely be negotiated with
independent parties;
(iii) Review with the independent auditors: (1) all of
their significant findings during the year, including the status
of previous audit recommendations; (2) any accounting
adjustments that were noted or proposed by the auditors but were
passed (as immaterial or otherwise); (3) any
communications between the audit team and the audit firms
national office respecting auditing or accounting issues
presented by the engagement; and (4) any
management or internal control letter
issued, or proposed to be issued, by the independent auditors to
the Company;
(iv) Review the Companys financial statements,
including: (1) prior to public release, reviewing with
management and the independent auditors the Companys
annual and quarterly financial statements to be filed with the
SEC, including (a) the Companys disclosures under
Managements Discussion and Analysis of Financial
Condition and Results of Operations, (b) any
certifications regarding the financial statements or the
Companys internal accounting and financial controls and
procedures and disclosure controls or procedures filed with SEC
by the Companys senior executive and financial officers
and (c) the matters required to be discussed by Statement
of Auditing Standards No. 61 or No. 71; (2) with
respect to the independent auditors annual audit report
and certification, before release of the annual audited
financial statements, meeting separately with the independent
auditors without any management member present and discussing
the adequacy of the Companys system of internal accounting
and financial controls and the appropriateness of the accounting
principles used in and the judgments made in the preparation of
the Companys audited financial statements and the quality
of the Companys financial reports; (3) making a
recommendation to the Board regarding the inclusion of the
audited annual financial statements in the Companys Annual
Report on
Form 10-K
to be filed with the SEC; and (4) prior to submission to
any governmental authority of any financial statements of the
Company that differ from the financial statements filed by the
Company with the SEC, reviewing such financial statements and
any report, certification or opinion thereon provided by the
independent auditors;
(v) At least annually, obtain and review a report by the
independent auditors describing: (1) the firms
internal quality-control procedures; (2) any material
issues raised by the most recent internal qualify-control review
or peer review of the firm, or by any inquiry or investigation
by governmental or professional authorities, within the
preceding five years regarding one or more independent audits
carried out by the firm and any steps taken to deal with any
such issues; and (3) all relationships between the
independent auditors and the Company (to be set out in the
formal written statement described below);
(vi) On an annual basis, request from the independent
auditors a formal written statement delineating all
relationships between the independent auditors and the Company,
consistent with Independence Standards Board Standard
No. 1. The Committee shall actively engage in a dialogue
with the independent auditors with respect to any disclosed
relationships or services that may impact the objectivity and
independence of the independent auditors and take appropriate
action in response to the independent auditors report to
satisfy themselves of the auditors independence. The
Committee shall also (1) consider whether, in the interest
of assuring continuing independence of the
A-3
independent auditors, the Company should regularly rotate its
independent auditors and (2) set clear hiring policies for
employees or former employees of the independent auditors;
(vii) Prepare a report to be included in the Companys
annual proxy statement stating whether or not the Committee:
(1) has reviewed and discussed the audited financial
statements with management; (2) has discussed with the
independent auditors the matters required to be discussed by SAS
No. 61 and 90; (3) has received the written disclosure
and letter from the independent auditors (delineating all
relationships they have with the Company) and has discussed with
them their independence; and (4) based on the review and
discussions referred to above, the members of the Committee
recommended to the Board that the audited financials be included
in the Companys Annual Report on
Form 10-K
for filing with the SEC; and
(viii) Conduct periodic self-evaluations of the performance
of the Committee, including its effectiveness and compliance
with the Charter of the Committee.
(c) When Necessary Activities
(i) Review and concur in the appointment, replacement,
reassignment or dismissal of the Chief Financial Officer or
Controller;
(ii) Have direct responsibility for the appointment,
evaluation, compensation and oversight of the work of the
independent auditors and, where appropriate, the dismissal of
the independent auditors;
(iii) Review periodically with general
and/or
outside counsel legal and regulatory matters that may have a
material impact on the Companys financial statement
compliance policies and programs; and
(iv) Inquire as to the view of the independent auditors of
the accounting treatment related to significant new transactions
or other significant matters or events not in the ordinary
course of business.
Adopted September 19, 2005
A-4
Appendix B
SYNERGETICS
USA, INC.
NOMINATING AND CORPORATE GOVERNANCE
COMMITTEE CHARTER
The Nominating and Corporate Governance Committee (the
Committee) shall assist the Board of Directors (the
Board) in fulfilling its responsibility to the
shareholders, potential shareholders and investment community
by: (1) identifying individuals qualified to serve as
directors and by selecting, or recommending the Board select,
the nominees for all directorships, whether such directorships
are filled by the Board or the shareholders; (2) developing
and recommending to the Board a set of corporate governance
guidelines and principles; (3) reviewing, on a regular
basis, the overall corporate governance of the Company and
recommending improvements when necessary; and
(4) overseeing and managing compliance with the
Companys Code of Business Conduct and Ethics as
established by management and the Board.
The Committee shall be comprised of three or more members of the
Board, each of whom is determined by the Board to be
independent in accordance with the rules and
guidelines of The Nasdaq Stock Market and any requirements and
rules adopted by the Securities and Exchange Commission relating
to nominating and corporate governance committees generally.
The members of the Committee shall be appointed by the Board and
continue to be members until their successors are elected and
qualified or until their earlier resignation or removal. The
Board may remove any member of the Committee, with or without
cause, at any time.
The Board may appoint one member to be the chairperson. If the
Board fails to appoint a chairperson, the members of the
Committee shall elect a chairperson by majority vote of all
members. The chairperson will chair all regular sessions of the
Committee and set the agendas for Committee meetings.
|
|
3.
|
COMMITTEE
MEETINGS; ACTION BY THE COMMITTEE
|
The Committee shall have regular meetings on a semi-annual
basis, or more frequently as circumstances dictate. Any member
of the Committee may call a special meeting of the Committee.
Meetings of the Committee may be held telephonically. A majority
of the members of the Committee shall constitute a quorum
sufficient for the taking of any action by the Committee.
The Committee may form and delegate any of its responsibilities
to a subcommittee so long as such subcommittee is comprised
solely of members of the Committee. The requirements for action
by a subcommittee shall, except as otherwise provided by act of
the Committee, be the same as applicable to the Committee.
All non-management directors who are not members of the
Committee may attend meetings of the Committee but may not vote.
In addition, the Committee may invite to its meetings any
director, member of management of the Company and such other
persons as it deems appropriate. The Committee may also exclude
from its meetings any persons it deems appropriate.
|
|
4.
|
RESPONSIBILITIES
AND AUTHORITY
|
The responsibilities of the Committee are set forth below. The
Committee shall also carry out any other responsibilities
assigned to it by the Board from time to time.
In fulfilling its responsibilities, the Committee may
investigate any matter brought to its attention. The Committee
may retain outside counsel or other advisors for this purpose
and will receive adequate funding from the Company to engage
such advisors.
B-1
(a) Board Selection and Evaluation
(i) Establish the standards and process for the selection
of individuals to serve on the Board;
(ii) Identify individuals qualified to serve as directors
and select, or recommend that the Board select, the nominees for
all directorships, whether such directorships are filled by the
Board or the shareholders, subject to any contractual or other
commitments of the Company. The Committee shall consider all
factors it deems relevant, including sound judgment, business
specialization, technical skills, diversity and the extent to
which the candidate would fill a present need on the Board;
(iii) Review each current member of the Board and
determine, or recommend to the full Board, whether such director
should stand for re-election;
(iv) Conduct all necessary and appropriate background
checks of potential candidates. In this regard, the Committee
shall have authority to retain the necessary experts to assist
it in identifying and reviewing candidates to serve as
directors. The Committee will receive its own funding from the
Company to engage such advisors;
(v) Review the independence and possible conflicts of
interest of members of the Board and executive officers; and
(vi) Oversee the evaluation of the Board and management.
(b) Corporate Governance
(i) Review the certificate of incorporation and by-laws of
the Company and recommend to the Board, if necessary, proposed
amendments for consideration by the shareholders; and
(ii) Establish and recommend to the Board a set of
corporate governance guidelines and principles.
(c) Reports
(i) Report regularly to the Board following each meeting.
The report to the Board may be an oral report and may be made at
any meeting of the Board; and
(ii) Maintain minutes or other records of the meetings and
activities of the Committee.
(d) Periodic Self-Evaluation
(i) Conduct periodic self-evaluations of the performance of
the Committee, including the effectiveness and compliance with
the Charter of the Committee. In addition, the Committee shall
periodically review and reassess the adequacy of this Charter
and recommend to the Board any improvements to this Charter that
the Committee considers necessary or valuable.
(e) Other
(i) Review and recommend to the Board any changes to the
compensation of directors;
(ii) Review and recommend to the Board any changes to the
Companys directors and officers
indemnification and insurance policies and arrangements; and
(iii) Review periodically with senior management the
provisions of the Companys Code of Business Conduct and
Ethics (including the Companys policies and procedures
with regard to trading by Company personnel in securities of the
Company and use in trading of proprietary or confidential
information) as adopted by the Board or senior management,
including any waivers provided under such code since the last
annual review; provided that any such wavier shall be reported
by the Committee to the Board, and approval of the Board shall
also be required for any such wavier applicable to any officer
who is a member of the Board.
Adopted September 19, 2005
B-2
ANNUAL MEETING OF STOCKHOLDERS OF
SYNERGETICS USA, INC.
November 30, 2006
Please date, sign and mail
your proxy card in the
envelope provided as soon
as possible.
â Please detach along perforated line and mail in the envelope provided. â
The Board of Directors recommends a vote FOR all director nominees.
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE x
1. Election of Directors:
|
|
|
|
|
|
|
|
|
|
|
NOMINEES: |
o
|
|
FOR ALL NOMINEES
|
|
¡
|
|
Robert H. Dick |
|
|
|
|
¡
|
|
Juanita H. Hinshaw |
o
|
|
WITHHOLD AUTHORITY
FOR ALL NOMINEES |
|
|
|
|
|
|
|
|
|
|
|
o
|
|
FOR ALL EXCEPT
(See instructions below) |
|
|
|
|
|
|
|
INSTRUCTION: |
|
To withhold authority to vote for any individual nominee(s), mark FOR ALL EXCEPT
and fill in the circle next to each nominee you wish to withhold, as shown here: l |
|
|
|
To change the address on your account, please check the box at right and
indicate your new address in the address space above. Please note that
changes to the registered name(s) on the account may not be submitted via
this method.
|
|
o |
2. |
|
IN THEIR DISCRETION, THE PROXIES ARE AUTHORIZED TO VOTE WITH
RESPECT TO ANY OTHER BUSINESS WHICH MAY PROPERLY COME
BEFORE THE ANNUAL MEETING OR AT ANY ADJOURNMENT THEREOF. |
This proxy, when properly executed, will be voted in the manner directed herein
by the undersigned stockholder. IF NO DIRECTION IS MADE, THIS PROXY WILL
BE VOTED FOR ALL PROPOSALS.
PLEASE SIGN, DATE AND RETURN THIS PROXY PROMPTLY USING THE
ENCLOSED ENVELOPE EVEN IF YOU PLAN TO ATTEND THE MEETING.
MARK X HERE IF YOU PLAN TO ATTEND THE MEETING. o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note:
|
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly,
each holder should sign. When signing as executor, administrator, attorney, trustee or guardian,
please give full title as such. If the signer is a corporation, please sign full corporate name by duly
authorized officer, giving full title as such. If signer is a partnership, please sign in
partnership name by authorized person. |
SYNERGETICS USA, INC.
PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF
SYNERGETICS USA, INC.
FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON NOVEMBER 30, 2006
The undersigned, having received the notice and accompanying Proxy Statement for said
meeting, hereby appoints Gregg D. Scheller and Pamela G. Boone, and each of them, with full
power of substitution, as the undersigneds proxy and attorney-in-fact to vote at the Annual
Meeting of Stockholders of Synergetics USA, Inc. (the Company) to be held on November 30, 2006
(the Annual Meeting), or at any adjournment thereof, all shares of voting stock of the Company
which the undersigned may be entitled to vote. The above proxies are hereby instructed to vote as
shown on the reverse of this card and in their discretion upon such other business as may properly
come before the Annual Meeting or at any adjournment thereof.
(Continued and to be signed on the reverse side.)
14475